A significant advance in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This essential tumor suppressor protein is frequently disabled in several types of tumors, leading https://livebookmarking.com/story21948836/mini-antibodies-restore-p53-new-potential-pathway-for-malignant-therapy